Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3146)
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,000
Price
$87.35
Total Value
$174.70K
Shares Held After
51,542
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
162
Price
$582.30
Total Value
$94.33K
Shares Held After
18,876
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,756
Price
$580.64
Total Value
$1.02M
Shares Held After
19,038
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,224
Price
$579.75
Total Value
$709.61K
Shares Held After
20,794
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,139
Price
$578.52
Total Value
$658.94K
Shares Held After
22,018
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,617
Price
$577.77
Total Value
$934.25K
Shares Held After
23,157
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,586
Price
$576.63
Total Value
$914.53K
Shares Held After
24,774
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,956
Price
$575.53
Total Value
$1.13M
Shares Held After
26,360
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$574.87
Total Value
$321.93K
Shares Held After
28,316
% of Holdings
1.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
8,224
Price
$89.84
Total Value
$738.84K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$89.00
Total Value
$222.50K
Shares Held After
53,542
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,670
Price
$87.11
Total Value
$232.59K
Shares Held After
56,042
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
3,094
Price
$86.62
Total Value
$268.00K
Shares Held After
58,712
% of Holdings
5.0%
Ginkgo Bioworks Holdings, Inc. (DNA)
Canton Barry — 10% Owner
Shares
13,116
Price
$6.40
Total Value
$83.90K
Shares Held After
338,568
% of Holdings
3.7%
Ginkgo Bioworks Holdings, Inc. (DNA)
Kelly Jason R — Director
Shares
109,767
Price
$6.40
Total Value
$702.18K
Shares Held After
316,483
% of Holdings
25.8%
Ginkgo Bioworks Holdings, Inc. (DNA)
Shetty Reshma P. — Director
Shares
13,116
Price
$6.40
Total Value
$83.90K
Shares Held After
338,568
% of Holdings
3.7%
Monte Rosa Therapeutics, Inc. (GLUE)
Nickson Philip — Chief Business & Legal Officer
Shares
5,845
Price
$17.69
Total Value
$103.41K
Shares Held After
55,000
% of Holdings
9.6%
EXOZYMES INC. (EXOZ)
Korman Tyler Paz — Chief Scientific Officer
Shares
750
Price
$10.53
Total Value
$7.89K
Shares Held After
729,123
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
38
Price
$581.45
Total Value
$22.10K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,482
Price
$580.84
Total Value
$860.81K
Shares Held After
40,551
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,046
Price
$580.07
Total Value
$606.75K
Shares Held After
42,033
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,140
Price
$578.83
Total Value
$659.86K
Shares Held After
43,079
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,815
Price
$577.90
Total Value
$1.05M
Shares Held After
44,219
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,478
Price
$576.69
Total Value
$852.35K
Shares Held After
46,034
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$575.75
Total Value
$714.51K
Shares Held After
47,512
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,260
Price
$575.04
Total Value
$724.54K
Shares Held After
48,753
% of Holdings
2.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
200
Price
$28.41
Total Value
$5.68K
Shares Held After
142,084
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
23,133
Price
$27.74
Total Value
$641.60K
Shares Held After
142,284
% of Holdings
14.0%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,800
Price
$15.00
Total Value
$27.00K
Shares Held After
213,867
% of Holdings
0.8%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Dev. & Operating Officer
Shares
85,163
Price
$40.10
Total Value
$3.42M
Shares Held After
105,289
% of Holdings
44.7%
Ginkgo Bioworks Holdings, Inc. (DNA)
Canton Barry — 10% Owner
Shares
13,155
Price
$6.93
Total Value
$91.16K
Shares Held After
351,684
% of Holdings
3.6%
Ginkgo Bioworks Holdings, Inc. (DNA)
Kelly Jason R — Director
Shares
97,015
Price
$6.93
Total Value
$672.31K
Shares Held After
426,250
% of Holdings
18.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Shetty Reshma P. — Director
Shares
13,155
Price
$6.93
Total Value
$91.16K
Shares Held After
351,684
% of Holdings
3.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
8,722
Price
$24.83
Total Value
$216.57K
Shares Held After
245,222
% of Holdings
3.4%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
5,165
Price
$24.83
Total Value
$128.25K
Shares Held After
183,231
% of Holdings
2.7%
EXOZYMES INC. (EXOZ)
Korman Tyler Paz — Chief Scientific Officer
Shares
750
Price
$10.04
Total Value
$7.53K
Shares Held After
729,873
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,518
Price
$24.83
Total Value
$37.69K
Shares Held After
254,439
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
8,614
Price
$24.83
Total Value
$213.89K
Shares Held After
255,957
% of Holdings
3.3%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
40,416
Price
$6.52
Total Value
$263.51K
Shares Held After
0
% of Holdings
100.0%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
32,523
Price
$6.29
Total Value
$204.57K
Shares Held After
0
% of Holdings
100.0%
Protara Therapeutics, Inc. (TARA)
Zummo Jacqueline — Chief R&D Officer
Shares
1,134
Price
$5.40
Total Value
$6.12K
Shares Held After
94,827
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$585.48
Total Value
$163.93K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
486
Price
$584.47
Total Value
$284.05K
Shares Held After
40,793
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$583.44
Total Value
$1.09M
Shares Held After
41,279
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,166
Price
$582.49
Total Value
$1.26M
Shares Held After
43,153
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,337
Price
$581.72
Total Value
$777.75K
Shares Held After
45,319
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
477
Price
$580.59
Total Value
$276.94K
Shares Held After
46,656
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$579.22
Total Value
$278.03K
Shares Held After
47,133
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$578.08
Total Value
$346.85K
Shares Held After
47,613
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$577.07
Total Value
$323.16K
Shares Held After
48,213
% of Holdings
1.1%
Showing 1–50 of 3146 transactions (page 1 of 63)